Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Open Access
- 7 June 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 92 (11) , 874-897
Abstract
DNA repair is a system of defenses designed to protect the integrity of the genome. Deficiencies in this system likely lead to the development of cancer. The epidemiology of DNA repair capacity and of its effect on cancer susceptibility in humans is, therefore, an important area of investigation. We have summarized all of the published epidemiologic studies on DNA repair in human cancer through 1998 (n = 64) that addressed the association of cancer susceptibility with a putative defect in DNA repair capacity. We have considered study design, subject characteristics, potential biases, confounding variables, and sources of technical variability. Assays of DNA repair capacity used, to date, can be broadly grouped into five categories: 1) tests based on DNA damage induced with chemicals or physical agents, such as the mutagen sensitivity assay, the G2-radiation assay, induced micronuclei, and the Comet assay; 2) indirect tests of DNA repair, such as unscheduled DNA synthesis; 3) tests based on more direct measures of repair kinetics, such as the host cell reactivation assay; 4) measures of genetic variation associated with DNA repair; and 5) combinations of more than one category of assay. The use of such tests in human populations yielded positive and consistent associations between DNA repair capacity and cancer occurrence (with odds ratios in the range of 1.4–75.3, with the majority of values between 2 and 10). However, the studies that we have reviewed have limitations, including small sample size, “convenience” controls, the use of cells different from the target organ, and the use of mutagens that do not occur in the natural environment. The evolving ability to study polymorphisms in DNA repair genes may contribute to new understandings about the mechanisms of DNA repair and the way in which DNA repair capacity affects the development of cancer.Keywords
This publication has 49 references indexed in Scilit:
- Rare microsatellite polymorphisms in the DNA repair genesXRCC1, XRCC3 andXRCC5 associated with cancer in patients of varying radiosensitivitySomatic Cell and Molecular Genetics, 1997
- DNA-damage processing in blood lymphocytes of head-and-neck-squamous-cell-carcinoma patients is dependent on tumor siteInternational Journal of Cancer, 1996
- DNA repair capacity as a risk factor for non‐melanocytic skin cancer—a molecular epidemiological studyInternational Journal of Cancer, 1994
- Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumorsInternational Journal of Cancer, 1994
- Do chemo- and radiotherapy affect the DNA repair ability of lymphocytes?Archives of Gynecology and Obstetrics, 1992
- Detection of benzo[a]pyrene-diol-epoxide-DNA adducts in white blood cells of psoriatic patients treated with coal tarMutation Research Letters, 1992
- Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador)European Journal of Cancer and Clinical Oncology, 1991
- Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesisInternational Journal of Cancer, 1989
- Impaired DNA-repair synthesis in lymphocytes of breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1986
- Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patientsCancer Genetics and Cytogenetics, 1985